{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:13:45Z","timestamp":1791764025831,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,8,20]],"date-time":"2027-08-20T00:00:00Z","timestamp":1818720000000},"content-version":"am","delay-in-days":384,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100001116","name":"Foundation Fighting Blindness Inc","doi-asserted-by":"publisher","award":["CD-C-0918\\u20130748-EEC"],"award-info":[{"award-number":["CD-C-0918\\u20130748-EEC"]}],"id":[{"id":"10.13039\/100001116","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["P30EY00630"],"award-info":[{"award-number":["P30EY00630"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010264","name":"Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010264","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["canadianjournalofophthalmology.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jcjo.2026.03.011","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T11:27:35Z","timestamp":1777030055000},"page":"999-1005","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Risk factors for pentosan polysulfate maculopathy"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9692-6443","authenticated-orcid":false,"given":"Sakshi","family":"Shiromani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2252-9891","authenticated-orcid":false,"given":"Afif","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaxian","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7622-3012","authenticated-orcid":false,"given":"Brian P.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian A.","family":"Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1971-5388","authenticated-orcid":false,"given":"Kenneth J.","family":"Rosengren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangqin","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2218-6611","authenticated-orcid":false,"given":"Nieraj","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjo.2026.03.011_bib0001","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.ophtha.2018.04.026","article-title":"Pigmentary maculopathy associated with chronic exposure to pentosan polysulfate sodium","volume":"125","author":"Pearce","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2026.03.011_bib0002","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1001\/jamaophthalmol.2022.6093","article-title":"Two-year outcomes after variable duration of drug cessation in patients with maculopathy associated with pentosan polysulfate use","volume":"141","author":"Jung","year":"2023","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jcjo.2026.03.011_bib0003","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3928\/23258160-20191009-10","article-title":"Progressive maculopathy after discontinuation of pentosan polysulfate sodium","volume":"50","author":"Huckfeldt","year":"2019","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.jcjo.2026.03.011_bib0004","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1001\/jamaophthalmol.2020.2349","article-title":"Disease course in patients with pentosan polysulfate sodium\u2013associated maculopathy after drug cessation","volume":"138","author":"Shah","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jcjo.2026.03.011_bib0005","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ajo.2024.12.004","article-title":"Pentosan polysulfate maculopathy: final outcomes from a 4-year prospective study of disease progression after drug cessation","volume":"217","author":"Hall","year":"2025","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2026.03.011_bib0006","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ajo.2023.05.021","article-title":"Progression of pentosan polysulfate sodium maculopathy in a prospective cohort","volume":"255","author":"Somisetty","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2026.03.011_bib0008","article-title":"Public awareness of a vision-threatening toxicity: infodemiology in pentosan polysulfate maculopathy [Internet]","year":"2024","journal-title":"JMIR Preprints"},{"key":"10.1016\/j.jcjo.2026.03.011_bib0009","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ajo.2021.02.025","article-title":"Pentosan polysulfate maculopathy: prevalence, spectrum of disease, and choroidal imaging analysis based on prospective screening","volume":"227","author":"Wang","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2026.03.011_bib0010","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.ophtha.2020.01.017","article-title":"Prevalence of maculopathy associated with long-term pentosan polysulfate therapy","volume":"127","author":"Vora","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2026.03.011_bib0011","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1136\/bjophthalmol-2019-314765","article-title":"Association of macular disease with long-term use of pentosan polysulfate sodium: findings from a US cohort","volume":"104","author":"Jain","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcjo.2026.03.011_bib0012","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1111\/bcp.15303","article-title":"Risk of maculopathy with pentosan polysulfate sodium use","volume":"88","author":"Bae","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jcjo.2026.03.011_bib0013","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1097\/IAE.0000000000003078","article-title":"Pentosan polysulfate and vision: findings from an international survey of exposed individuals","volume":"41","author":"Uner","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.jcjo.2026.03.011_bib0014","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.survophthal.2024.12.002","article-title":"Pentosan polysulfate sodium maculopathy: final analysis of a prospective cohort, updated review, and association with inflammatory bowel disease","volume":"70","author":"Santina","year":"2025","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jcjo.2026.03.011_bib0015","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.ophtha.2019.04.024","article-title":"Strength of association between pentosan polysulfate and a novel maculopathy","volume":"126","author":"Hanif","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2026.03.011_bib0016","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/ICB.0000000000001090","article-title":"Potential new-onset clinically detectable pentosan polysulfate maculopathy years after drug cessation","volume":"16","author":"Barnett","year":"2022","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.jcjo.2026.03.011_bib0017","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1494467","article-title":"Colopathy associated with pentosan polysulfate use","volume":"16","author":"Jung","year":"2025","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jcjo.2026.03.011_bib0018","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jcjo.2019.12.001","article-title":"Pentosan-associated maculopathy: prevalence, screening guidelines, and spectrum of findings based on prospective multimodal analysis","volume":"55","author":"Wang","year":"2020","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jcjo.2026.03.011_bib0019","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/jamaophthalmol.2019.3392","article-title":"Phenotypic spectrum of pentosan polysulfate sodium-associated maculopathy: a multicenter study","volume":"137","author":"Hanif","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jcjo.2026.03.011_bib0020","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ophtha.2017.09.028","article-title":"Consensus definition for atrophy associated with age-related macular degeneration on OCT: Classification of Atrophy Report 3","volume":"125","author":"Sadda","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2026.03.011_bib0021","first-page":"421","article-title":"Evaluation of different methods used to calculate ideal body weight in the pediatric population","volume":"24","author":"Kang","year":"2019","journal-title":"J Pediatr Pharmacol Ther"},{"key":"10.1016\/j.jcjo.2026.03.011_bib0022","first-page":"2594","article-title":"Association and prevalence of pentosan polysulfate sodium use with drug related maculopathy","volume":"64","author":"Arias","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jcjo.2026.03.011_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2025.101400","article-title":"Pentosan polysulfate maculopathy: clinical considerations, pathobiology, and causality","volume":"109","author":"Hall","year":"2025","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.jcjo.2026.03.011_bib0024","first-page":"11867","article-title":"Re: Review - Proctor JG. Pentosan polysulfate and a pigmentary maculopathy: causation versus correlation?","volume":"31","author":"Foote","year":"2024","journal-title":"Can J Urol"},{"key":"10.1016\/j.jcjo.2026.03.011_bib0025","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1200\/JCO.2018.78.3290","article-title":"Sex differences in efficacy and toxicity of systemic treatments: an undervalued issue in the era of precision oncology","volume":"36","author":"\u00d6zdemir","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jcjo.2026.03.011_bib0026","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.10677","article-title":"Risk factors for hydroxychloroquine retinopathy and its subtypes","volume":"7","author":"Jorge","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jcjo.2026.03.011_bib0027","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1167\/iovs.61.13.33","article-title":"Visual function in pentosan polysulfate sodium maculopathy","volume":"61","author":"Lyons","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jcjo.2026.03.011_bib0028","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s13181-015-0488-6","article-title":"A review of the toxicologic implications of obesity","volume":"11","author":"Zuckerman","year":"2015","journal-title":"J Med Toxicol"},{"key":"10.1016\/j.jcjo.2026.03.011_bib0030","article-title":"Obesity related alterations in pharmacokinetics and pharmacodynamics of drugs: emerging clinical implications in obese patients\u2014Part I","volume":"9","author":"Telessy","year":"2017","journal-title":"Adipobiology"},{"key":"10.1016\/j.jcjo.2026.03.011_bib0032","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s00192-021-04711-3","article-title":"Does irritable bowel syndrome increase the risk of interstitial cystitis\/bladder pain syndrome? A cohort study of long term follow-up","volume":"32","author":"Chang","year":"2021","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.jcjo.2026.03.011_bib0033","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1097\/IAE.0000000000003794","article-title":"Pentosan polysulfate sodium (Elmiron) maculopathy: a genetic perspective","volume":"43","author":"Kalaw","year":"2023","journal-title":"Retina"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418226000876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418226000876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T19:18:14Z","timestamp":1787512694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008418226000876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0008418226000876"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjo.2026.03.011","relation":{},"ISSN":["0008-4182"],"issn-type":[{"value":"0008-4182","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for pentosan polysulfate maculopathy","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjo.2026.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}